USTM Scientist Contributes to Global Health Study
Ri-Bhoi, Meghalaya, 26th June 2026: In a significant achievement for the scientific community of Northeast India, Dr. Yugal Kishore Mohanta, Assistant Professor in the Department of Applied Biology at USTM and Senior Collaborator of the Global Burden of Disease (GBD) Study at the Institute for Health Metrics and Evaluation (IHME), Washington University, USA, has contributed to a landmark international research publication in The Lancet Infectious Diseases, one of the world’s most prestigious medical journals with an impact factor of 31.0.
The study, titled “Global Burden of Enteric Infectious Diseases, Diarrhoeal Diseases, and Corresponding Aetiologies, 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023,” presents the most comprehensive assessment to date of the global burden of diarrhoeal and enteric infectious diseases over the last three decades. The research analyses disease prevalence, mortality, disability, and the major pathogens responsible for these illnesses across countries and regions worldwide.
The findings reveal that despite substantial improvements in sanitation, healthcare access, and disease prevention measures, diarrhoeal and enteric infections continue to remain major public health challenges, particularly in low- and middle-income countries. The study provides critical evidence for policymakers, healthcare professionals, and global health organisations to design targeted interventions and strategies aimed at reducing disease burden and improving health outcomes.
Speaking on the achievement, Dr. Mohanta said, “Being part of such a globally significant study is both an honour and a responsibility. The Global Burden of Disease initiative generates evidence that is vital for informed decision-making in public health. The findings of this study will contribute to a better understanding of disease patterns and help governments and health agencies allocate resources more effectively for disease prevention and control.”
Prof. G.D. Sharma, Vice Chancellor of USTM, congratulated Dr Mohanta and said, “This achievement is a matter of immense pride for USTM and the entire Northeast region. Dr Mohanta’s contribution to a globally acclaimed study published in The Lancet Infectious Diseases highlights the quality of research being undertaken at the university.
The Global Burden of Disease Study, coordinated by the Institute for Health Metrics and Evaluation (IHME), is regarded as the world’s most comprehensive effort to measure epidemiological trends, disease burden, and health outcomes across countries. Its findings serve as an essential resource for governments, researchers, and international organisations in shaping evidence-based health policies and interventions worldwide.
About the University of Science and Technology Meghalaya (USTM):
Established in 2011, the University of Science and Technology Meghalaya (USTM) is the first state private university in the field of Science and Technology in North East India. The University was accredited with an ‘A Grade’ by the National Assessment and Accreditation Council (NAAC) in its first cycle of assessment in 2021. USTM remains committed to excellence in teaching, research, innovation, and community engagement, while promoting inclusivity, sustainability, and regional development.